ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0548

Postural Orthostatic Tachycardia Syndrome, Small Fiber Neuropathy, and Systemic Inflammation: Are They Related?

Elizabeth Bettini, Carolyn Ramwell, Sangeeta Sule and Jeffery Moak, Children's National Hospital, Washington, DC

Meeting: ACR Convergence 2022

Keywords: Autoinflammatory diseases, Biomarkers, Ehlers-Danlos, Inflammation, Pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Abstracts: Exemplary Interprofessional Research

Session Type: Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Postural Orthostatic Tachycardia Syndrome (POTS) is a dysautonomia associated with chronic autonomic and neuropathic symptoms, including pain in multiple body regions, paresthesia, fatigue, brain fog, tachycardia, dizziness, and syncope. Many have co-morbid symptoms of rheumatologic disease such as arthralgia and myalgia, with a number having a family history of autoimmune conditions or hypermobile Ehrler’s Danlos syndrome (JH). Small fiber autonomic neuropathy (SFAN) affects nociceptive nerve fibers and has been noted in Fibromyalgia. The purpose of this study is to define the occurrence and associations of small fiber neuropathy in children, adolescents, and young adults (CAYA) with POTS and marked compromised quality of life.

Methods: Patients with dysautonomia presenting with neuropathic symptoms to a pediatric clinic that diagnoses and treats autonomic disease were offered epidermal skin biopsy (ESB) to test for SFAN. Electronic medical records were reviewed for those tested from December 2020-April 2022. Data collected were ESB findings, laboratory blood studies, and subjective and objective recorded clinical variables.

Results: Sixty-two records reviewed: 87% female (n=54), mean age of 16 years (range 10-21), and 95% (n=59) Caucasian race. Sixty-eight % (n=42) were positive for SFAN by EBS, 45% (n=19) of ESB positive had an antecedent inflammatory event such as infection, surgery, or head concussion, and 64% (n=27) had JH with a Beighton score ³6/9. Chi Square test for independence demonstrated a significant association between JH and ESB (x2 =4.71, p=0.03). Of those that completed serum testing, 45% of the total sample were ANA positive, which correlated with a history of an inflammatory event (r=0.27, p=0.02.) Thyroid antibodies were found in 14% of ESB positive and were absent in all ESB negative. ESR and CRP were each elevated in 4 patients, with 100% those elevated ESB positive. SFAN on ESB was associated with the presence of antibodies, and ESR or CRP elevations (x2 =4.70, p=0.02).

Conclusion: SFAN and the presence of blood markers of inflammation are common in CAYA with POTS; those with JH potentially more often affected. These results may suggest a secondarily associated autoimmune processes triggered by the inflammatory event. Whether treatment with an anti-inflammatory agent might benefit POTS patients with SFN needs to be explored.


Disclosures: E. Bettini, None; C. Ramwell, None; S. Sule, None; J. Moak, None.

To cite this abstract in AMA style:

Bettini E, Ramwell C, Sule S, Moak J. Postural Orthostatic Tachycardia Syndrome, Small Fiber Neuropathy, and Systemic Inflammation: Are They Related? [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/postural-orthostatic-tachycardia-syndrome-small-fiber-neuropathy-and-systemic-inflammation-are-they-related/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/postural-orthostatic-tachycardia-syndrome-small-fiber-neuropathy-and-systemic-inflammation-are-they-related/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology